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EDITORIAL REVIEW 
"Hibernating" Myocardium: Asleep 
WILLIAM F. ARMSTRONG,  MD, FACC 
Ann Arbor, Michigan 
or Part Dead? 
Chronic ischemic dysfunction of the left ventricle is commonly 
presumed to represent "hibernating" myocardium. The implica- 
tion of this assumption is that with successful reperfusion, systolic 
function will improve. Several diagnostic techniques including 
dobutamine stress echocardiography have been used to detect 
"viable" myocardium in the setting of chronic left ventricular 
dysfunction. Predictive accuracies of 70% to 85% have been 
reported for identifying myocardium that recovers function. Re- 
covery of function has been variable and often dependent on the 
severity of dysfunction. All current models have presumed that 
chronically dysfunctioning myocardium is "hibernating." Obvi- 
ously, in the chronic setting, dysfunction may have many causes 
and include components of transmural and nontransmural infarc- 
tion as well as hibernating myocardium. This review focuses on 
the independent role that nontransmural infarction may play in 
chronic dysfunction and suggests its impact on diagnostic tech- 
niques used to identify hibernating myocardium. 
(J Am Coll Cardiol 1996;28:530-5) 
The accurate identification of "hibernating" and "stunned" 
myocardium and separation of these entities from infarcted 
myocardium has become a major goal in cardiovascular imag- 
ing. Accurate identification of viable myocardium ay allow a 
more rational recommendation f r coronary revascularization. 
The underlying premise is that viable but dysfunctional myo- 
cardium will recover function if revascularized. The two enti- 
ties under consideration, myocardial stunning and hibernation, 
are distinct with respect o their origin and natural history. 
Myocardial stunning is a well defined phenomenon that is the 
result of an acute ischemic insult (1-5). Excellent animal 
models for myocardial stunning exist and the human corollar- 
ies of the stunning that occurs after coronary angioplasty and 
after lytic therapy have been fairly well described (5,6). Myo- 
cardial hibernation refers to chronic ischemic dysfunction of 
myocardium subtended by a critical coronary stenosis (7,8). 
The mechanism for chronic dysfunction is probably multifac- 
torial--including ultrastructural alterations of the myocardium 
(9), calcium overload (10) and depletion of adenosine triphos- 
phate (ll)--which result in excitation-contraction uncoupling. 
Unlike acute ischemic stunning, clinically relevant myocardial 
hibernation has no effective animal models. 
Methods  fo r  Detect ing  V iab le  Myocard ium 
Several techniques have been proposed for the detection of 
myocardial viability. These have included the early techniques 
of postextrasystolic potentiation (12), redistribution thallium 
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techniques (13-16) and positron emission tomography for 
evaluation of myocardial metabolism and perfusion (17,18). 
More recently, the response to low dose dobutamine aug- 
mentation of acutely stunned (19-21) or chronically dysfunc- 
tioning (22-29) myocardium has been described. The standard 
for viability in most studies has been recovery of systolic 
function. As discussed subsequently, this may be an inappro- 
priate standard for myocardial viability. Comparative studies 
have suggested rough equivalence among these techniques 
with respect o predicting recovery of function, and overall 
predictive accuracies range from 70% to 85% (23,25-27,29). In
general, the techniques tend to agree more for myocardial 
segments hat have relatively mild degrees of dysfunction and 
less well for segments that are frankly akinetic (23,27,29). 
Radionuclide and metabolic studies tend to predict more 
viable segments han are apparent by echocardiographic imag- 
ing (25,27,28). The rest echocardiogram alone provides valu- 
able clues to myocardial viability. Myocardial segments that 
have preserved wall thickness and are only hypokinetic (as 
opposed to akinetic) more often are viable when evaluated 
with more complex techniques such as dobutamine augmenta- 
tion or perfusion imaging (26,28). Recently, myocardial con- 
trast echocardiography has also been shown to be a marker of 
myocardial viability (30,31) but likewise to predict more viable 
segments han are apparent by dobutamine augmentation (32). 
The ability of dobutamine stress echocardiography to detect 
stunned myocardium and to separate it from irreversibly 
infarcted myocardium was first demonstrated byPierfird and 
colleagues (19). After myocardial infarction, they noted that 
patients with dobutamine augmentation had intact metabolism 
but that only those with preserved flow had subsequent recov- 
ery of function. There was an excellent concordance b tween 
nonviability by positron emission tomography and failure to 
augment with low dose dobutamine. In a similar fashion, 
Barilla and colleagues (20) suggested that dobutamine aug- 
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mentation was a marker for viable myocardium but that 
recovery of function occurred only if the infarct vessel was 
revascularized. Myocardial stunning, by definition, is a tran- 
sient phenomenon. Once vessel patency has been documented, 
the incremental value of a diagnostic test such as dobutamine 
stress echocardiography or thallium perfusion imaging may be 
quite limited. Conversely, hibernation is a more clinically 
relevant arget for investigation, as the patency of coronary 
arteries is often unknown but obstructive coronary disease 
presumably exists. In patients with chronic ischemic dysfunc- 
tion, identification of potentially viable myocardium ay pro- 
vide the impetus for revascularization in an effort to improve 
left ventricular systolic function, reduce symptoms of heart 
failure and, presumably, improve survival. 
Prevalence of Hibernation and Its Response 
to Revascularization 
The actual prevalence of hibernating myocardium remains 
unknown. Several studies (22-29,33) have indirectly addressed 
the issue, and from these it appears that a substantial propor- 
tion of patients with chronic oronary artery disease may have 
myocardial segments best described as hibernating. An early 
study by Lewis and colleagues (33) evaluated 252 consecutive 
patients who presented with chest pain but had not had 
documented myocardial infarction. Wall motion abnormalities 
at rest were noted on echocardiography in 77 (31%) of these 
patients, 32 of whom subsequently underwent revasculariza- 
tion. Follow-up echocardiograms were available in 19 patients 
and demonstrated improved segmental wall motion in the 
majority. More recently, Afridi and colleagues (23) evaluated 
20 patients with severe coronary disease who subsequently 
underwent successful balloon dilation. Rest wall motion ab- 
normalities were present in all. After successful angioplasty, 
recovery of baseline function occurred in 33% of dysfunctional 
segments. As with the earlier study of Lewis et al. (33), the 
presumption was that the rest wall motion abnormalities 
represented chronic ischemic dysfunction due to hibernation, 
which then reversed after estitution of normal coronary blood 
flow. 
Standards for Viability 
The appropriate standard for determining viability is not 
the presence of metabolic activity with positron emission 
tomography, perfusion on thallium redistribution or systolic 
augmentation during dobutamine infusion. The appropriate 
standard is recovery of function and reduction in symptoms 
after revascularization. The currently employed iagnostic 
techniques are designed simply as markers of myocardial 
viability rather than as the standard. Several definitions of 
recovery of function can be utilized. Mechanical function can 
be analyzed on either a regional or a global basis. Investiga- 
tional data support improvement in either or both. Many 
patients presumed to have hibernation probably have a corn- 
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Figure 1. Relation of percent myocardial infarct thickness to systolic 
thickening. Complete cessation of systolic thickening occurs at a 
threshold of 21% infarct hickness, and a significant decrease in wall 
thickening is seen with a lesser degree of nontransmural infarction. 
Reprinted from Lieberman etal. (37) with permission fthe American 
Heart Association. 
bination of hibernation and nontransmural infarction, and the 
latter may result in a failure to recover baseline function. In 
these instances, recovery of cardiovascular reserve, ideally 
quantified by increasing exercise tolerance and decreasing 
symptoms, is likewise a marker of myocardial viability. Finally, 
patient survival is probably the ultimate goal of preservation f 
viable myocardium. Two recent studies (34,35) have suggested 
that patients with areas of viable myocardium who undergo 
revascularization have a lower event rate than do those without 
revascularization. 
Just as the optimal standard for viability has not been fully 
established, the "threshold" level of viable myocardium re- 
quired to be present to provide clinical benefit after revascu- 
larization has not been determined. It has been suggested (26) 
that revascularization f only 18% of the left ventricle may 
reduce the frequency of subsequent clinical events. A greater 
mass of myocardial viability may be necessary for revascular- 
ization to result in augmented left ventricular function at rest. 
Role of Nontransmural  Infarction 
It has been known for more than a decade that a threshold 
of myocardial injury occurs, after which regional wall motion 
becomes abnormal (37,38). Recently, the disproportionate role 
that the subendocardial l yer of myocardium plays in overall 
wall thickening was further elucidated (39,40). The early 
animal work by Lieberman et al. (37) suggested that gross 
systolic dysfunction did not occur in a myocardial region until 
the transmural extent of necrosis exceeded 20% (Fig. 1). 
Above the threshold of 20% wall thickness necrosis, there was 
an abrupt cessation of systolic function (37). The clinical 
corollary of this experimental study is that a patient with a 
nontransmural myocardial infarction involving only 5% to 10% 
of the wall thickness will have essentially normal function at 
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Figure 2. Hypothetic relation between dobutamine r sponses and 
degree of nontransmural infarction. Anticipated responses at baseline 
(BASE) and low, intermediate and peak doses of dobutamine stimu- 
lation are presented as they relate to degrees of nontransmural 
infarction ranging from 0 to 100%. This hypothetic model hypothesizes 
decreased baseline function with increasing degrees oftransmurality of 
infarction with blunted augmentation dependent onpercent myocar- 
dial infarction. 
rest in that region. A segment with fully transmural infarction 
obviously has no motion at baseline. At a threshold of infarc- 
tion of -20% transmurality, rest function would be anticipated 
to be markedly abnormal. However, as 80% of the wall 
thickness i  viable, augmentation with low dose dobutamine, or
presumably with physiologic exercise, would result in improved 
function in that region. Obviously one can extrapolate grada- 
tions of responses of the myocardium to incremental dobut- 
amine infusion (and presumably to physiologic exercise) de- 
pendent on the degree of transmural infarction. Figure 2 is a 
schematic of the hypothesized responses of myocardium to 
graded dobutamine infusions depending on the degree of 
myocardial necrosis present. This scheme assumes normal 
coronary flow to the remaining viable myocardium. Two 
recently published animal studies (41,42) have indirectly sup- 
ported this concept. 
The "Ischemic Cardiomyopathy" 
Virtually all patients with chronic ischemic dysfunction and 
congestive heart failure have a combination of previous non- 
transmural myocardial infarction (often unrecognized) as well 
as multiple areas of myocardial hibernation and of normal 
perfusion and function. Thus, the combinations of responses 
seen are far more complex than the ~pical biphasic response 
of augmentation followed by deterioration or continued aug- 
mentation (23,43). Figure 3 outlines a variety of contractile 
responses that appear theoretically sound on the basis of 
current data. Many of these responses have been clinically 
demonstrated. 
The simplest scenarios represent the major extremes (Fig. 
3, panels A to C). Panels A and B represent fully normal or 
fully infarcted myocardium. Panel C represents he situation of 
full thickness tunned or hibernating myocardium. During low 
dose dobutamine infusion, inotropic stimulation is sufficient to 
overcome the depression of contractility and wall motion 
increases. With increasing doses of dobutamine, oxygen de- 
mand increases, and in the presence of critical coronary 
stenosis, ischemia ensues and wall motion deteriorates. It has 
been suggested (23) that this biphasic response, indicating 
viable myocardium subtended by a critical coronary stenosis, 
may be the most accurate chocardiographic marker of myo- 
cardial viability. The level at which the response becomes 
biphasic--that is,turns from augmentation to deterioration-- 
presumably is related to the severity, of the coronary stenosis 
and the magnitude of flow reduction. If appropriately revas- 
cularized, such a segment would be expected to recover 
function and to have near normal systolic reserve. 
Intermediate l vels of nontransmural infarction would be 
expected to augment only at higher doses of dobutamine 
[~  Normal 
Infarct Rest Augmented Tracer 
Hibernating Normal Infarct Hibernating Motion Motion Uptake 
A ~ 100% 0% 0% ~ ~ 100% 
B 0% 100% 0% ~ m 0% 
C ~ 0% 0% 100% mmmm ~ 50% 
o ~  ss% 15% 0% ~ ~ sSO/o 
E ~ 0% 15% 85% aammm ~ 42.5% 
F ~ 75% 25% 0% ~ m~m 75% 
G ~ 50% 50% 0% ~ ~ 50% 
14 ~ 0% 25% 75% ~ ~ 30% 
I ~ 0% 50% 50% ~ um~ 25% 
Recovery Preservation 
of Rest of Systolic 
Function Reserve 
Yes Yes 
No No 
Yes Yes 
Yes Yes 
Yes Yes 
No Yes 
No ? 
No Yes 
No ? 
Figure 3. Synopsis of anticipated dobutamine aug- 
mentation responses and likelihood of recovery of 
baseline function and preservation f systolic reserve 
based on different proportion of normal, infarcted 
and hibernating myocardium. See text for details. 
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infusion (Fig. 2). One could hence hypothesize that systolic 
augmentation atany level of dobutamine infusion serves as a 
marker of viable tissue; however, only segments that augment 
with low dose stimulation have the requisite mass of viable 
myocardium to recover basal function after revascularization. 
Although it appears that the underlying pathophysiology 
(43) and clinical implication (23) of the biphasic response have 
been reasonably well elucidated, the pathogenesis and impli- 
cations of other responses such as continued worsening, con- 
tinued improvement and no change are less well understood. 
The biphasic response clearly represents augmentation of 
myocardium with sufficient mass to override the hibernating 
phenomenon or nontransmural infarct area, which then dete- 
riorates at higher metabolic loads. Sustained improvement 
would be expected to occur in the presence of hibernating 
myocardium or of nontransmural infarction when no critical 
coronary stenosis is present. Thus, revascularization f such an 
area, because there is no underlying critical stenosis, would not 
result in improved baseline function. Myocardial segments hat 
show no response may either epresent hibernation to a degree 
that increasing metabolic activity is not feasible or segments in
which a threshold of nontransmural infarction has been 
reached such that the doses of dobutamine infused are not 
sufficient to result in augmentation (Fig. 2). Although no 
definite evidence xists to prove any of the preceding hypoth- 
eses, many of these scenarios can be supported by drawing on 
known observations. 
Hypothetically, and using the data of Lieberman and col- 
leagues (37), as a starting reference, a segment of myocardium 
with 20% transmural myocardial infarction would be expected 
to be hypokinetic or akinetic at rest. However, as 80% of the 
wall is viable, augmentation at low levels of dobutamine may 
allow the viable myocardium to override the infarct area. In 
this situation augmentation f systolic function would occur at 
low doses of inotropic stimulation. The next stage of myocar- 
dial necrosis would be typified by a segment with 30% to 40% 
transmural necrosis. In this instance, as for the 20% transmural 
infarct, rest function would be abnormal. Because the ratio of 
normal to infarcted myocardium is lower than in the previous 
example, augmentation will not occur until intermediate doses 
of dobutamine are employed. At higher doses, ischemia may 
again ensue and wall motion deteriorate. The preceding exam- 
ples presume a fairly simple distinction between infarcted and 
normal myocardium. In the latter case, however, revascular- 
ization would not result in recovery of baseline systolic func- 
tion because the 20% threshold of myocardial necrosis has 
been exceeded (Fig. 3, panels F to I). However, as perfusion to 
the remaining normal myocardium has been restored, systolic 
reserve may be restored. 
Hibernating myocardium will behave in a virtually identical 
manner to that just noted. Hypothetically, in the preceding 
scenario, one could substitute hibernating myocardium for 
normally contracting myocardium in varying ratios. When this 
occurs, the same patterns of increasing contractility at variable 
low and intermediate doses of dobutamine would be antici- 
pated, with further deterioration athigher doses depending on 
the severity of flow-limiting coronary stenoses. Both of these 
scenarios probably occur clinically, obviously could coexist in 
any given patient and may be indistinguishable from an 
imaging standpoint. 
Role of Radionuclide Imaging 
Radionuclide imaging techniques likewise have proved 
valuable methods for detecting myocardial viability (13- 
16,25,27,29). Positron emission tomography, with imaging to 
detect metabolic activity, has been considered a reference 
standard for viable myocardium (17-19,28). As noted earlier, 
metabolic activity is not the appropriate standard; rather, 
recovery of function and improved symptomatic status are 
more appropriate nd points. Both thallium scintigraphy and 
dobutamine echocardiography compare favorably with 
positron emission tomography, although in general positron 
emission tomography tends to detect more viable segments 
than the other two techniques. On the basis of these consid- 
erations, one should expect discrepancies among viability 
determinations obtained with metabolic tracers, flow tracers 
and functional assessment as each technique has a different 
threshold level of activity or function for separating viable from 
nonviable myocardium. Because the spatial resolution of ra- 
dionuclide imaging techniques i not sufficient o accurately 
determine myocardial thickness, nontransmural myocardial 
infarction cannot be reliably detected on the basis of scinti- 
graphic anatomy. On the basis of assumed kinetics of thallium 
activity, nontransmural infarction should be manifest as re- 
duced overall wall activity. In a similar fashion, chronic reduc- 
tion in myocardial flow also will be manifest as reduced 
thallium activity. 
By using very simple assumptions, anticipated thallium 
patterns can then be fit to the echocardiographic responses and 
patterns of anatomy depicted in Figure 3. Assuming that 
normal myocardium, subtended by a nonflow restrictive coro- 
nary artery, has a thallium uptake of 100% and that fully 
infarcted myocardium has a thallium uptake of 0%, fairly 
simple and obvious patterns can be derived. If one then 
assumes that hibernating myocardium subtended by a critically 
stenosed coronary artery has an initial activity level of 50% of 
normal myocardium, anticipated levels of thallium activity for 
the different combinations of the normal, hibernating and 
infarcted myocardium presented in Figure 3 can then be 
predicted. On the basis of these fairly simple assumptions, it 
should be appreciated that a range of thallium activity can be 
present in the different combinations of infarct/normal/ 
hibernating myocardium. Depending on the balance of normal 
versus hibernating myocardium, an individual myocardial seg- 
ment may have recovery of function with a relatively low 
thallium uptake whereas a neighboring segment with higher 
thallium uptake may not recover est function. This would be 
typified by comparing examples E, F and G in Figure 3. In 
example E, 15% transmural myocardial infarction is present, 
but the remaining 85% is hibernating. One would anticipate a
thallium activity of -40%. Because 85% of the myocardium is
534 ARMSTRONG JACC Vol. 28, No. 2 
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viable, it would be expected to recover function after reperfu- 
sion; hence, an -40% thallium uptake would be associated 
with recovery of function. Panel G represents a situation in 
which there is a 50% transmural infarct with normal perfusion 
of the remaining 50% of the myocardium. Thallium activity 
would be expected to be 50% (probably indistinguishable from 
the 42.5% in panel E), yet recovery of function would not occur 
because of the underlying extent of the nontransmural infarc- 
tion. Panel F represents a situation in which 25% of the wall 
thickness is infarcted. One would anticipate thallium activity of 
75%, possibly indistinguishable from normal; however, recov- 
ery of function would not occur because of the underlying 
myocardial infarction. On the basis of these fairly simple 
assumptions and the obvious corollaries to dobutamine re- 
sponses, one should not expect 100% concordance among the 
diagnostic tests, or between any given diagnostic test and 
regional recovery of function. Obviously the initial and delayed 
thallium activity will be dependent on timing of imaging after 
injection and the actual severity of flow-limiting lesions. 
Mechanism of Patient Improvement and 
Improved Survival 
Clinicians have long linked reduced systolic function to 
worsened survival and symptomatic status. It appears that, as 
revascularization is extended to higher isk patients with worse 
left ventricular systolic function, surgical outcome may be 
more favorable than previously presumed. The mechanism by 
which this occurs is probably twofold. First and simplest, 
revascularization reduces the likelihood of new ischemic epi- 
sodes, protects myocardium that is potentially viable and at 
least arrests any further deterioration in systolic function. 
Second, although revascularization cannot reduce the total 
amount of nontransmural myocardial infarction, by improving 
myocardial flow to the hibernating myocardium it allows 
recovery of those segments and, in some cases, recovery of 
baseline function. By improving function to both hibernating 
and nonhibernating myocardium, even in regions with >20% 
nontransmural infarction, there may be restitution of systolic 
reserve, such that during physiologic stress the normally per- 
fused residual myocardium ay be able to override the adverse 
effects of nontransmural segments with overall improvement of
function. These events would have an obviously beneficial 
effect on exercise tolerance and symptoms of congestive heart 
failure. 
Summary and Conclusion 
Myocardial hibernation, nontransmural infarction and nor- 
mally functioning nonischemic myocardium probably all coex- 
ist in any given patient with chronic ischemic left ventricular 
function. The current methodologies of dobutamine augmen- 
tation and thallium redistribution appear to be accurate mark- 
ers for myocardial segments that contain viable myocardium 
but may be less accurate in predicting segment by segment 
recovery because of the mixed nature of the previous ischemic 
insult. Nevertheless, patients with substantial areas of viable 
myocardium will have regions likely to recover baseline func- 
tion as well as regions with recovery of systolic reserve. 
Whereas restitution of baseline function will result in an 
increase in baseline systolic performance, restoration of flow to 
regions with greater degrees of nontransmural infarction will 
not. However, in the latter instance, cardiac reserve will be 
protected and symptomatic status will presumably improve. 
Therefore, failure of rest function to improve after revascular- 
ization should be construed not as a failure of the diagnostic 
test but as a limitation of the factors noted. 
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